Pharmacotherapies for attention-deficit/hyperactivity disorder: Expected-cost analysis
Albert Marchetti, Raf Magar, Helen Lau, Erin L. Murphy, Peter S. Jensen, Keith C. Conners, Robert Findling, Elliot Wineburg, Isabel Carotenuto, Thomas R. Einarson, Michael Iskedjian
Dive into the research topics of 'Pharmacotherapies for attention-deficit/hyperactivity disorder: Expected-cost analysis'. Together they form a unique fingerprint.